Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation.

Saved in:
Bibliographic Details
Title: Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation.
Authors: Yu, Jing1 (AUTHOR), Powers III, John H.2 (AUTHOR), Vallo, David3 (AUTHOR), Falloon, Judith1,3 (AUTHOR) falloonj@vielabio.com, Powers, John H 3rd2 (AUTHOR)
Source: Value in Health. Feb2020, Vol. 23 Issue 2, p227-235. 9p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2019.09.2747